GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates AS (OCSE:VIRO) » Definitions » Accounts Payable & Accrued Expense

ViroGates AS (OCSE:VIRO) Accounts Payable & Accrued Expense : kr0.51 Mil (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is ViroGates AS Accounts Payable & Accrued Expense?

ViroGates AS's quarterly accounts payable & accrued expense declined from Sep. 2024 (kr0.49 Mil) to Dec. 2024 (kr0.28 Mil) but then increased from Dec. 2024 (kr0.28 Mil) to Mar. 2025 (kr0.51 Mil).

ViroGates AS's annual accounts payable & accrued expense increased from Dec. 2022 (kr0.57 Mil) to Dec. 2023 (kr1.56 Mil) but then declined from Dec. 2023 (kr1.56 Mil) to Dec. 2024 (kr0.28 Mil).

ViroGates AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for ViroGates AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates AS Accounts Payable & Accrued Expense Chart

ViroGates AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only 3.65 0.38 0.57 1.56 0.28

ViroGates AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.54 0.49 0.28 0.51

ViroGates AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ViroGates AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates AS (OCSE:VIRO) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
OCSE:SMSMED ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD XAMS:PHIA XSWX:SOON ZBH SHSE:688271 TSE:7733 LSE:SN. ASX:COH TSE:6869 PEN
Traded in Other Exchanges
EP2:Germany
Address
Banevaenget 13, Birkerod, DNK, DK-3460
Website
https://www.virogates.com
ViroGates AS is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates AS Headlines

No Headlines